About 10% of patients with eating disorders have misused GLP-1 receptor agonists

The use and misuse of GLP-1 receptor agonists were “common” among patients with eating disorders, according to a research letter published in JAMA Psychiatry.Some patients with eating disorders also have used compounded and illicit drugs, Nicholas C. Peiper, PhD, MPH, a professor in the department of epidemiology and population health at the University of Louisville, and colleagues